Press Release

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Freshworks Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FRSH

NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Freshworks Inc. (NASDAQ: FRSH) pursuant and/or traceable to the Company’s initial public offering conducted in September 2021 (the “IPO”), of the important January 3, 2023 lead plaintiff deadline. SO WHAT: If you purchased Freshworks securities […]

Read more
Press Release

Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial

mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a statistically significant and clinically meaningful reduction in the risk of disease recurrence or death compared to KEYTRUDA monotherapy in stage III/IV melanoma patients with high risk of recurrence following complete resection Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical […]

Read more